IL96924A0 - Imidazole derivatives,process for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
Imidazole derivatives,process for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL96924A0 IL96924A0 IL96924A IL9692491A IL96924A0 IL 96924 A0 IL96924 A0 IL 96924A0 IL 96924 A IL96924 A IL 96924A IL 9692491 A IL9692491 A IL 9692491A IL 96924 A0 IL96924 A0 IL 96924A0
- Authority
- IL
- Israel
- Prior art keywords
- imidazole derivatives
- preparation
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004357 Transferases Human genes 0.000 abstract 1
- 108090000992 Transferases Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- -1 acyl coenzyme-A Chemical compound 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005516 coenzyme A Substances 0.000 abstract 1
- 229940093530 coenzyme a Drugs 0.000 abstract 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Plural Heterocyclic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Polyurethanes Or Polyureas (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909000696A GB9000696D0 (en) | 1990-01-12 | 1990-01-12 | New compositions of matter |
| GB909027892A GB9027892D0 (en) | 1990-12-21 | 1990-12-21 | Imidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL96924A0 true IL96924A0 (en) | 1992-03-29 |
Family
ID=26296489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL96924A IL96924A0 (en) | 1990-01-12 | 1991-01-10 | Imidazole derivatives,process for the preparation thereof and pharmaceutical compositions containing the same |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0510036B1 (cs) |
| JP (1) | JPH05503095A (cs) |
| KR (1) | KR927003576A (cs) |
| AT (1) | ATE121401T1 (cs) |
| AU (1) | AU7066191A (cs) |
| CA (1) | CA2073443A1 (cs) |
| CS (1) | CS5291A3 (cs) |
| DE (1) | DE69109090T2 (cs) |
| FI (1) | FI923189A7 (cs) |
| HU (1) | HUT61540A (cs) |
| IE (1) | IE910098A1 (cs) |
| IL (1) | IL96924A0 (cs) |
| MX (1) | MX9203711A (cs) |
| NO (1) | NO922729L (cs) |
| NZ (1) | NZ236763A (cs) |
| PT (1) | PT96467A (cs) |
| WO (1) | WO1991010662A1 (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019838D0 (en) * | 1990-09-11 | 1990-10-24 | Smith Kline French Lab | Compounds |
| US5212318A (en) * | 1991-03-04 | 1993-05-18 | Eastman Kodak Company | Preparation of omega-substituted alkanamide |
| GB9115005D0 (en) * | 1991-07-11 | 1991-08-28 | Rhone Poulenc Rorer Ltd | Novel compositions of matter |
| GB9115190D0 (en) * | 1991-07-12 | 1991-08-28 | Rhone Poulenc Rorer Ltd | New compositions of matter |
| US5310748A (en) * | 1992-05-11 | 1994-05-10 | The Du Pont Merck Pharmaceutical Company | Imidazoles for the treatment of atherosclerosis |
| US5364875A (en) * | 1992-05-11 | 1994-11-15 | The Du Pont Merck Pharmaceutical Company | Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis |
| IT1265209B1 (it) * | 1993-11-22 | 1996-10-31 | Pierrel Spa | Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro |
| US5491152A (en) * | 1994-03-23 | 1996-02-13 | The Du Pont Merck Pharmaceutical Company | Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| DE10114775A1 (de) * | 2001-03-26 | 2002-10-10 | Gerhard Dannhardt | 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie |
| DE10238045A1 (de) | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| MD4150C1 (ro) * | 2011-10-11 | 2012-09-30 | Институт Химии Академии Наук Молдовы | Procedeu de obţinere a compuşilor coordinativi ai Co(II), Ni(II) şi Zn(II) cu 2-nitro-4,5-difenilimidazol pornind de la 4,5-difenilimidazol şi nitraţii metalelor respective |
| MD4178C1 (ro) * | 2012-02-27 | 2013-02-28 | Институт Химии Академии Наук Молдовы | Procedeu de obţinere a 2-nitro-4,5-difenilimidazolului |
| CN106699738A (zh) * | 2015-11-18 | 2017-05-24 | 南京大学 | 一类含甲硝唑吡唑类骨架的抗菌化合物的设计、合成及生物活性评价 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3323870A1 (de) * | 1983-07-02 | 1985-01-03 | A. Nattermann & Cie GmbH, 5000 Köln | Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DK167187A (da) * | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
| US4900744A (en) * | 1988-09-14 | 1990-02-13 | E. I. Du Pont De Nemours And Company | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles |
-
1991
- 1991-01-09 AU AU70661/91A patent/AU7066191A/en not_active Abandoned
- 1991-01-09 JP JP3502230A patent/JPH05503095A/ja active Pending
- 1991-01-09 MX MX9203711A patent/MX9203711A/es unknown
- 1991-01-09 HU HU9422A patent/HUT61540A/hu unknown
- 1991-01-09 WO PCT/EP1991/000023 patent/WO1991010662A1/en not_active Ceased
- 1991-01-09 AT AT91901788T patent/ATE121401T1/de not_active IP Right Cessation
- 1991-01-09 DE DE69109090T patent/DE69109090T2/de not_active Expired - Fee Related
- 1991-01-09 EP EP91901788A patent/EP0510036B1/en not_active Expired - Lifetime
- 1991-01-09 FI FI923189A patent/FI923189A7/fi not_active Application Discontinuation
- 1991-01-09 CA CA002073443A patent/CA2073443A1/en not_active Abandoned
- 1991-01-09 KR KR1019920701647A patent/KR927003576A/ko not_active Withdrawn
- 1991-01-10 IL IL96924A patent/IL96924A0/xx unknown
- 1991-01-11 PT PT96467A patent/PT96467A/pt not_active Application Discontinuation
- 1991-01-11 CS CS9152A patent/CS5291A3/cs unknown
- 1991-01-11 IE IE009891A patent/IE910098A1/en unknown
- 1991-01-14 NZ NZ236763A patent/NZ236763A/xx unknown
-
1992
- 1992-07-10 NO NO92922729A patent/NO922729L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE910098A1 (en) | 1991-07-17 |
| CS5291A3 (en) | 1992-02-19 |
| JPH05503095A (ja) | 1993-05-27 |
| NZ236763A (en) | 1993-05-26 |
| FI923189A0 (fi) | 1992-07-10 |
| DE69109090T2 (de) | 1995-09-14 |
| NO922729D0 (no) | 1992-07-10 |
| HUT61540A (en) | 1993-01-28 |
| EP0510036A1 (en) | 1992-10-28 |
| KR927003576A (ko) | 1992-12-18 |
| FI923189L (fi) | 1992-07-10 |
| PT96467A (pt) | 1991-10-15 |
| AU7066191A (en) | 1991-08-05 |
| WO1991010662A1 (en) | 1991-07-25 |
| CA2073443A1 (en) | 1991-07-13 |
| ATE121401T1 (de) | 1995-05-15 |
| MX9203711A (es) | 1992-07-01 |
| NO922729L (no) | 1992-09-02 |
| EP0510036B1 (en) | 1995-04-19 |
| HU9202294D0 (en) | 1992-10-28 |
| FI923189A7 (fi) | 1992-07-10 |
| DE69109090D1 (de) | 1995-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL96924A0 (en) | Imidazole derivatives,process for the preparation thereof and pharmaceutical compositions containing the same | |
| TW349946B (en) | Novel naphthyl compounds and their process for preparation and pharmaceutical compositions containing same | |
| KR940002942B1 (en) | Process for preparing antimycotic nail varnish | |
| HUT37128A (en) | Process for the production of dihydropyridazinone-derivatives, as well as of pharmaceutical preparations containing these derivatives as agent | |
| MX9800946A (es) | Derivados de 4-mercaptopirrolidina como inhibidores de farnesil trasnferasa. | |
| AU589427B2 (en) | Pyridonecarboxylic acid derivatives and process for their preparation | |
| EG15921A (en) | Method of preparation pyrrolidine derivatives | |
| HU895226D0 (en) | Process for the preparation of novel imidazoline derivatives and pharmaceutical compositions containing said compounds as active ingredients | |
| GB1254332A (en) | Amino acids and their derivatives and processes for preparing them | |
| ES8609225A1 (es) | Un procedimiento para preparar un derivado de semicarbazida | |
| YU217181A (en) | Process for preparing 2-(1,4-benzodioxane-2-ylalkyl)-imidazoles | |
| DE3061125D1 (en) | 1-(naphthyl-n-propyl)imidazole derivatives, compositions containing them, methods of making them and their use for pharmaceuticals | |
| ES484718A1 (es) | Un procedimiento para la preparacion de benzopiranos. | |
| HU906230D0 (en) | Process for the preparation of benzanilide derivatives and medical preparations containing them | |
| ES8609212A1 (es) | Un procedimiento para la preparacion de derivados de etanolamina. | |
| EP0123962A3 (en) | Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition | |
| NO170974C (no) | Analogifremgangsmaate for fremstilling av terapeutisk brukbare ((((3-pyridinyl)metylen)amino)oksy)alkansyrer og estere derav samt mellomprodukt for anvendelse ved fremgangsmaaten | |
| DE3070768D1 (en) | 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them | |
| AP1518A (en) | Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds. | |
| DE3374005D1 (en) | 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle | |
| DE3362876D1 (en) | Dibenzocycloheptenylidene compounds for use in modulating the immune response | |
| IL115085A0 (en) | Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| DE3475402D1 (en) | Endo-8,8-dialkyl-8-azoniabicyclo (3.2.1) octane-6,7-exo-epoxy-3-alkyl-carboxylate salts, a process for their preparation, and therapeutic compositions which contain them as active principle | |
| ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| IL70552A (en) | Aminoethoxybenzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them |